CD40 expression on human lung cancer correlates with metastatic spread |
| |
Authors: | Michael S Sabel Makoto Yamada Yoshihiro Kawaguchi Fang-An Chen Hiroshi Takita Richard B Bankert |
| |
Institution: | (1) Division of Surgery, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA e-mail: msabel@sc3101.med.buffalo.edu Tel.: +1-716-845-8455; Fax: +1-716-845-8906, US;(2) Department of Surgery, Gifu University School of Medicine, Gifu 500, Japan, JP;(3) Department of Immunology, Roswell Part Cancer Institute, Buffalo, NY 14263, USA, US |
| |
Abstract: | Purpose: The poor prognosis associated with lung cancer is related to the high incidence of regional and distant metastasis. There
is a crucial need to identify parameters that can predict a tendancy to metastatic spread to allow better prognostic evaluation
and therapeutic approach. Methods: Using flow cytometry we evaluated 18 human lung cancer cell lines for the expression of different surface markers on lung
cancers suggested to be possible prognostic parameters, including epidermal growth factor receptor (EGFR), intercellular adhesion
molecule 1 (ICAM-1), Fas and CD40. Results: No correlation was found between tumor prognosis and EGFR, ICAM-1 or Fas. However, a statistically significant correlation
was found between the surface expression of CD40 and the metastatic spread of the tumor. In this study, 14 of 18 lung cancer
cell lines (78%) expressed CD40 on their surface. All of the 4 tumors that were CD40-negative, were stage I tumors, without
any evidence of regional or distant metastasis. Of the 14 tumors that expressed CD40, all but 1 (93%) had either nodal or
systemic metastasis at the time of diagnosis. Patients whose tumors were CD40-negative showed a significantly better N stage,
overall stage at presentation and survival than those patients with CD40-positive patients. No significant differences between
the two groups were observed in tumor size, gender, age, histology, differentiation or preoperative therapy. Conclusions: These results suggest that CD40 expression on lung cancer may play a role in metastatic spread, and also may serve as a prognostic
marker and an indicator of advanced disease.
Received: 30 August 1999 / Accepted: 22 December 1999 |
| |
Keywords: | CD40 Metastases EGFR FAS ICAM-1 |
本文献已被 PubMed SpringerLink 等数据库收录! |
|